Walleye Capital
VERA icon

Walleye Capital’s Vera Therapeutics VERA Stock Holding History

Walleye Capital’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$932K Buy
23,156
+8,230
+55% +$355K 0.01% 2136
2025
Q4 		$756K Buy
14,926
+2,875
+24% +$102K ﹤0.01% 2651
2025
Q3 		$350K Sell
12,051
-4,478
-27% -$104K ﹤0.01% 2888
2025
Q2 		$389K Sell
16,529
-182,130
-92% -$4.1M ﹤0.01% 2848
2025
Q1 		$4.77M Buy
+198,659
New +$6.38M 0.05% 818
2023
Q2 		– Sell
-10,100
Closed -$78.4K – 5317
2023
Q1 		$78.4K Sell
10,100
-219,104
-96% -$1.69M ﹤0.01% 3050
2022
Q4 		$4.44M Buy
+229,204
New +$4.15M 0.1% 298

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return